Carasent ASA
The answer first
Does Carasent beat the market?
No, Carasent has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 48% of Nordic stocks
- Quality65
- Value27
- Trend62
No. 62 of 195 in healthcare
Expectations in the price
High expectations
For the share to return about 9% a year from today's price, the cash Carasent keeps must grow about 11% a year for 10 years.
Max for seven days
Follow Carasent with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 20 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Carasent
Your first answer is free, no account needed.
Do you own Carasent, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Carasent and a few more. Free, no card.
Super Stock+45.3%In short
- Carasent has fallen 9.4% over the past year, including dividends.
- Overall, Carasent ranks better than 48% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 77.0%. The price is 43.2% below its peak now.
What do analysts think of Carasent?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 48% of Nordic stocks.
No. 62 of 195 in healthcare
Medium An average company: the accounts are neither especially strong nor weak.
No. 98 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.05
- Asset turnoverSales divided by everything the company owns0.40
- Return on equityProfit divided by equity+4.9%
- Cash conversionOperating cash flow divided by profit2.39
The ranking is built on equity ratio, ROA and how steadily profit grows.
Low High price: buyers pay a lot today, often because they expect growth.
No. 78 of 197 in healthcareTypical in healthcare: 19Typical in the Nordics: 50
- P/BPrice divided by equity2.0
- P/SPrice divided by sales4.1
- P/EPrice divided by earnings40.9
- P/CFPrice divided by operating cash flow17.1
The ranking is built on P/E, P/B and P/S.
Medium The share price has moved about like most stocks over the last year.
No. 60 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months−3.2%
- 6 months+5.6%
- 9 months+6.3%
- 12 months−9.4%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
The funds that own Carasent
8 funds we follow own Carasent. The share is how much of the fund the stock makes up.
- Norway1
- Sweden7
- Lannebo Hälsa och Ny Teknik ASweden · Lannebo4.7%
- Didner & Gerge Small & MicrocapSweden · Didner2.5%
- PLUS Mikrobolag Sverige IndexSweden · PLUS1.0%
- PLUS Hälsovård Sverige IndexSweden · PLUS0.5%
- Handelsbanken Norden Ind Crit (A1 NOK)Sweden · Handelsbanken0.1%
- Skandia Småbolag Sverige Exponering ASweden · Skandia0.1%
- KLP AksjeNorden IndeksNorway · KLP0.0%
- Skandia Världen SverigeSweden · Skandia0.0%
From the funds' latest known holdings.
About Carasent
Carasent ASA is a company in healthcare, listed on Nasdaq Stockholm. By market value, Carasent is number 33 of 137 companies in healthcare on Nasdaq Stockholm. Carasent has not paid a dividend in the past twelve months. Of the three measures in the ranking, Carasent is strongest on quality, better than 65% of Nordic stocks. The share trades in SEK. It has around 230 employees.
Carasent AB (publ) provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany. The company offers Webdoc, Webcur, Metodika, Ad Curis, Ad Opus, and Data-AL solutions. It also provides Medrave, Vårdrummet, Ad Voca, and HPI Plustoo services, as well as an ecosystem of platform services, including solutions for patient communication and business intelligence. The company was founded in 1997 and is headquartered in Gothenburg, Sweden.


See the full analysis of Carasent.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card